Zobrazeno 1 - 10
of 315
pro vyhledávání: '"C, Thivolet"'
Autor:
S. Villar Fimbel, M. Gaudilliere, C. Thivolet, Marc Nicolino, N. Bendelac, B. Mestre, N. Protsenko, S. Brunot
Publikováno v:
Acta Diabetologica
Objectives The study aims at evaluating glucose metrics and HbA1C values after pump initiation in outpatient settings. Research design and methods This single center observational study enrolled 121 subjects with type 1 diabetes between September 202
Autor:
C. Thivolet
Publikováno v:
Médecine des Maladies Métaboliques
Médecine des Maladies Métaboliques, Elsevier, 2020, 14, pp.732-737. ⟨10.1016/j.mmm.2020.07.004⟩
Médecine des Maladies Métaboliques, Elsevier, 2020, 14, pp.732-737. ⟨10.1016/j.mmm.2020.07.004⟩
Resume Le diabete de type 1 (DT1) se definit par la necessite de suppleer a la carence de production d’insuline par le pancreas. De nombreux elements experimentaux et cliniques ont permis de correler cette situation clinique qui se manifeste, souve
Autor:
R Cassel, S Ducreux, M R Alam, F Dingreville, C Berlé, K Burda-Jacob, M A Chauvin, K Chikh, L Païta, R Al-Mawla, C Crola Da Silva, J Rieusset, C Thivolet, F Van Coppenolle, A M Madec
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148686 (2016)
Type 2 diabetes is characterized by peripheral insulin resistance and pancreatic beta cell dysfunction. Elevated free fatty acids (FFAs) may impair beta cell function and mass (lipotoxicity). Altered calcium homeostasis may be involved in defective i
Externí odkaz:
https://doaj.org/article/5db260fd1d0a4d95b6557bb2379d9cc8
Publikováno v:
Diabetes & Metabolism. 48:101396
Autor:
FL Velayoudom, S Lion, Etienne Larger, S Clavel, C. Thivolet, Jean-François Gautier, Nathalie Jeandidier, P.Y. Benhamou, E. Bismuth, Michael Joubert, Emmanuel Cosson, Guy Fagherazzi, Pierre Fontaine, B. Vergès, Hélène Hanaire, Jean-Pierre Riveline, Bruno Detournay, L Bordier, H Servy, A. Sola-Gazagnes, S Picard, Ronan Roussel, Amélie Bonnefond, Eric Vicaut, Jacques Beltrand, L Sablone, S Tubiana
Publikováno v:
Diabetesmetabolism. 48(3)
Type 1 diabetes mellitus (T1DM) is associated with a high risk of cardiovascular (CV) complications, even after controlling for traditional CV risk factors. Therefore, determinants of the residual increased CV morbidity and mortality remain to be dis
Autor:
Sylvia Franc, N Filhol, Yves Reznik, Pierre-Yves Benhamou, Jerome Place, C Guillot, Pauline Schaepelynck, A Desserprix, Anne Farret, E. Bonnemaison, Sophie Borot, Eric Renard, B. Delemer, D Durain, P. Serusclat, Marion Munch, Lucy Chaillous, Isabelle Guilhem, A. Penfornis, A. Sola-Gazagnes, N. Tubiana-Rufi, Sfd Sfd Paramedical Sfe Sfedp Ajd Ffd Fenarediam, Guillaume Charpentier, Jacques Beltrand, R. Leroy, Michael Joubert, Cnp-Edn, Bruno Guerci, Jean-Pierre Riveline, V. Melki, S Picard, C Abettan, C. Thivolet, Sandrine Lablanche, Hélène Hanaire, E. Bismuth, Nathalie Jeandidier
Publikováno v:
Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
International audience; Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to significantly improve the quality of care for adults, adolescents and children with type 1 diabetes. To improve access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c2a286638b450215d247a5f42b92ce
https://hal.umontpellier.fr/hal-03269986
https://hal.umontpellier.fr/hal-03269986
Publikováno v:
Diabetesmetabolism. 47(6)
To assess, in a real-life setting, the effectiveness of telemonitoring adults with type 1 diabetes (T1D) using continuous glucose monitoring in a telemedicine experiment.Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAP
Publikováno v:
Diabetes & Metabolism
Diabetes mellitus is challenging in the context of the COVID-19 pandemic. The prevalence of diabetes patients hospitalized in intensive care units for COVID-19 is two- to threefold higher, and the mortality rate at least double, than that of non-diab
Autor:
Charlène Telliam, C. Thivolet
Publikováno v:
Diabetes Care
Diabetes Care, 2020, 43 (4), pp.e52--e53. ⟨10.2337/dc19-2586⟩
Diabetes Care, 2020, 43 (4), pp.e52--e53. ⟨10.2337/dc19-2586⟩
In the January 2020 issue of Diabetes Care , Soupal et al. (1) provided convincing evidence that continuous glucose monitoring (CGM) by itself is superior to self-monitoring of blood glucose in reducing HbA1c and hypoglycemia, whatever the type of in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d8be9d5f38da7d63c5f8f2ba46a040
https://hal.archives-ouvertes.fr/hal-02901895
https://hal.archives-ouvertes.fr/hal-02901895
Publikováno v:
Diabetes & Metabolism. 46:73-74
Diabetes & Metabolism - In Press.Proof corrected by the author Available online since vendredi 13 avril 2018